Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Clinical trial NCT03982004 · TERMINATED
Trial details
- NCT number
- NCT03982004
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2021-03-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.